BOMBSHELL: Pfizer admits to conducting gain-of-function research, building SARS-CoV-2 in its own labs
Tuesday, February 15, 2022 by: Ethan Huff
(Natural News) In a shocking (or perhaps not) admission, Albert Bourla, the CEO of Pfizer, openly admitted that his company created the Wuhan coronavirus (Covid-19) in a laboratory in order to then manufacture and sell “vaccines” for it.
Bourla fessed up to the truth during an interview with CNBC back in late December. He explained how SARS-CoV-2, as opposed to a naturally occurring coronavirus, was specifically deployed in order to develop the company’s mRNA (messenger RNA) gene therapy injections.
Bourla also revealed that Pfizer is currently reformulating said mRNA gene therapy injections in order to treat the all-new “omicron” (moronic) variant of the Fauci Flu, which is barely even a cold (if it even exists at all).
“The data that we received are data that they got from what we call a pseudo-virus, so it’s not the real virus,” Bourla declared. “It is a virus that we have constructed in our labs and it is identical with the omicron virus.”
A pseudo-virus, by the way, is a recombinant (genetically engineered) virus particle that has been scientifically manipulated using several other viruses. The purpose is to make the final GMO virus more pathogenic than its parts otherwise would have been in nature.
“In other words, Bourla admitted Pfizer is conducting gain of function research in pursuit of creating an Omicron vaccine,” reported Newspunch.
Be the first to Comment.
Blogger's note: subterrnews.blogspot.com does not send cookies, or collect any information on those using the blog. However, the blogspot is on google, and google may collect information, and send cookies. Many of the links that we connect to do not send out cookies or collect information, but some do. You are keying in to this blog, and you have agreed to this.
The views of the author do not necessarily represent the opinions of this blog. They are the views, and opinions of the author(s) of the article.
0 comments:
Post a Comment